Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development

References

• Liu D, Gao SX, Liao HF, Xu JM, Wen M. A Comparative Study of 2 Different Segmentation Methods of ADC Histogram for Differentiation Genetic Subtypes in Lower-Grade Diffuse Gliomas. Biomed Res Int. 2020;2020:9549361. doi:10.1155/2020/9549361
   PubMed Web of Science ®Google Scholar
• Yaqub M, Jinchao F, Zia MS, et al. State-of-The-Art CNN Optimizer for Brain Tumor Segmentation in Magnetic Resonance Images. Brain Sci. 2020;10(7):427. doi:10.3390/brainsci10070427
   PubMed Web of Science ®Google Scholar
• Gao P, Wang H, Li H, et al. miR-21-5p Inhibits the Proliferation, Migration, and Invasion of Glioma by Targeting S100A10. J Cancer. 2023;14(10):1781–1793. doi:10.7150/jca.84030
   PubMed Web of Science ®Google Scholar
• Han X, Xue X, Zhou H, Zhang G. A molecular view of the radioresistance of gliomas. Oncotarget. 2017;8(59):100931–100941. doi:10.18632/oncotarget.21753
   PubMedGoogle Scholar
• Wang H, Yin M, Ye L, et al. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis. Technol Cancer Res Treat. 2021;20:15330338211011961. doi:10.1177/15330338211011961
   Google Scholar
• Wang H, Mao X, Ye L, Cheng H, Dai X. The Role of the S100 Protein Family in Glioma. J Cancer. 2022;13(10):3022–3030. doi:10.7150/jca.73365
   PubMed Web of Science ®Google Scholar
• Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476:1–12. doi:10.1016/j.canlet.2020.02.002
   PubMed Web of Science ®Google Scholar
• Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15(7):422–442. doi:10.1038/s41571-018-0003-5
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Sasada T. Cancer Vaccines: toward the Next Breakthrough in Cancer Immunotherapy. J Immunol Res. 2020;2020:5825401. doi:10.1155/2020/5825401
   PubMed Web of Science ®Google Scholar
• Crane CA, Han SJ, Ahn B, et al. Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res. 2013;19(1):205–214. doi:10.1158/1078-0432.CCR-11-3358
   PubMed Web of Science ®Google Scholar
• Platten M, Bunse L, Wick A, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. 2021;592(7854):463–468. doi:10.1038/s41586-021-03363-z
   PubMed Web of Science ®Google Scholar
• Bezu L, Kepp O, Cerrato G, et al. Trial watch: peptide-based vaccines in anticancer therapy. Oncoimmunology. 2018;7(12):e1511506. doi:10.1080/2162402X.2018.1511506
   PubMed Web of Science ®Google Scholar
• Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother. 2005;54(8):721–728. doi:10.1007/s00262-004-0653-2
   PubMed Web of Science ®Google Scholar
• Faghfuri E, Pourfarzi F, Faghfouri AH, Abdoli Shadbad M, Hajiasgharzadeh K, Baradaran B. Recent developments of RNA-based vaccines in cancer immunotherapy. Expert Opin Biol Ther. 2021;21(2):201–218. doi:10.1080/14712598.2020.1815704
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Mason PW, Geall A, Mandl CW. RNA-based vaccines. Vaccine. 2012;30(30):4414–4418. doi:10.1016/j.vaccine.2012.04.060
   PubMed Web of Science ®Google Scholar
• Grunwitz C, Kranz LM. mRNA Cancer Vaccines-Messages that Prevail. Curr Top Microbiol Immunol. 2017;405:145–164. doi:10.1007/82_2017_509
   PubMed Web of Science ®Google Scholar
• Cafri G, Gartner JJ, Zaks T, et al. mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer. J Clin Invest. 2020;130(11):5976–5988. doi:10.1172/JCI134915
   PubMed Web of Science ®Google Scholar
• Rausch S, Schwentner C, Stenzl A, Bedke J. mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer. Hum Vaccin Immunother. 2014;10(11):3146–3152. doi:10.4161/hv.29553
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125. doi:10.1038/s41422-020-00441-1
   PubMed Web of Science ®Google Scholar
• Recht L, Torres CO, Smith TW, Raso V, Griffin TW. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg. 1990;72(6):941–945. doi:10.3171/jns.1990.72.6.0941
   PubMed Web of Science ®Google Scholar
• Han W, Xin Z, Zhao Z, et al. RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3. J Clin Invest. 2013;123(5):2103–2118. doi:10.1172/JCI61820
   PubMed Web of Science ®Google Scholar
• Forcina GC, Dixon SJ. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis. Proteomics. 2019;19(18):e1800311. doi:10.1002/pmic.201800311
   PubMed Web of Science ®Google Scholar
• Liu T, Zhu C, Chen X, et al. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro Oncol. 2022;24(7):1113–1125. doi:10.1093/neuonc/noac033
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. A Physiological Function for Ferroptosis in Tumor Suppression by the Immune System. Cell Metab. 2019;30(1):14–15. doi:10.1016/j.cmet.2019.06.012
   PubMed Web of Science ®Google Scholar
• Gui CP, Li JY, Fu LM, et al. Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer. J Big Data. 2022;9(1):88. doi:10.1186/s40537-022-00641-z
   PubMedGoogle Scholar
• Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database. 2020;2020. doi:10.1093/database/baaa021
   Google Scholar
• Huang X, Tang T, Zhang G, Liang T. Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development. Mol Cancer. 2021;20(1):50. doi:10.1186/s12943-021-01342-6
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):l1. doi:10.1126/scisignal.2004088
   Web of Science ®Google Scholar
• Tran TO, Vo TH, Lam L, Le N. ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: comprehensive multi-omics analysis. Comput Struct Biotechnol J. 2023;21:1921–1929. doi:10.1016/j.csbj.2023.02.045
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. doi:10.1186/s13059-017-1349-1
   PubMed Web of Science ®Google Scholar
• Wang T, Dai L, Shen S, et al. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. Front Immunol. 2022;13:843408. doi:10.3389/fimmu.2022.843408
   PubMed Web of Science ®Google Scholar
• Dang HH, Ta H, Nguyen T, et al. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation. Funct Integr Genomics. 2022;22(5):1057–1072. doi:10.1007/s10142-022-00883-3
   PubMed Web of Science ®Google Scholar
• Wang D, Burns R, Khalil M, Mei A, Hashemi E, Malarkannan S. Methods to Analyze the Developmental Trajectory of Human Primary NK Cells Using Monocle and SCENIC Analyses. Methods Mol Biol. 2022;2463:81–102.
   PubMedGoogle Scholar
• Zhang X, Zhang Y, Zhao L, et al. Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer. Front Immunol. 2022;13:1014638. doi:10.3389/fimmu.2022.1014638
   PubMed Web of Science ®Google Scholar
• Wang W, Green M, Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270–274. doi:10.1038/s41586-019-1170-y
   PubMed Web of Science ®Google Scholar
• Majercikova Z, Dibdiakova K, Gala M, et al. Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells. Int J Mol Sci. 2022;23(18):10883. doi:10.3390/ijms231810883
   PubMed Web of Science ®Google Scholar
• Guo S, King P, Liang E, Guo AA, Liu M. LncRNA HOTAIR sponges miR-301a-3p to promote glioblastoma proliferation and invasion through upregulating FOSL1. Cell Signal. 2022;94:110306. doi:10.1016/j.cellsig.2022.110306
   PubMed Web of Science ®Google Scholar
• Du L, Xing Z, Tao B, et al. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway. Signal Transduct Target Ther. 2020;5(1):10. doi:10.1038/s41392-019-0103-4
   PubMed Web of Science ®Google Scholar
• Tang J, Xu J, Zhi Z, et al. MiR-876-3p targets KIF20A to block JAK2/STAT3 pathway in glioma. Am J Transl Res. 2019;11(8):4957–4966.
   PubMed Web of Science ®Google Scholar
• Li J, Gu J, Wang J, et al. MicroRNA-433-3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2. Brain Behav. 2022;12(12):e2632. doi:10.1002/brb3.2632
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang D, Aleksandrovich KD, et al. RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux. Front Oncol. 2022;12:887294. doi:10.3389/fonc.2022.887294
   PubMed Web of Science ®Google Scholar
• Priambada D, Thohar Arifin M, Saputro A, et al. Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma Patients. Int J Gen Med. 2023;16:393–403. doi:10.2147/IJGM.S397550
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang X, Yan Z, Zhang M. Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development. Cancer Med. 2022;11(13):2711–2726. doi:10.1002/cam4.4633
   PubMed Web of Science ®Google Scholar